By using drugs currently used to treat other diseases, scientists hope they will help children with leukemia suffer fewer long-term aftereffects from their treatment.
Aug 31, 2022
0
2
For patients with acute decompensated heart failure, the addition of acetazolamide to loop diuretic therapy yields an increased incidence of successful decongestion, according to a study published online Aug. 27 in the New ...
Aug 29, 2022
0
0
The EAST—AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention) trial investigated whether rhythm control therapy—with antiarrhythmic drugs or atrial fibrillation ablation—delivered within one year after ...
Aug 29, 2022
0
4
The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischemic heart disease, according to late breaking research ...
Aug 29, 2022
0
0
Illicit drug use is associated with a nearly nine-fold greater risk of death or life-threatening emergencies in intensive cardiac care unit (ICCU) patients, according to research presented at ESC Congress 2022.
Aug 26, 2022
0
4
Cannabis prescribed for chronic pain is associated with an elevated risk of heart rhythm disorders, according to research presented at ESC Congress 2022.
Aug 22, 2022
0
16
A new study led by Monash University researchers has, for the first time, shown that the chemical compound "nitroxyl" may represent an effective and rapid intervention for cardiovascular emergencies in type 2 diabetes mellitus ...
Aug 16, 2022
0
6
The largest medical record-based study ever of adverse events suffered by hospitalized patients in the U.S., published in the July 12 issue of JAMA, reports a significant decrease in the rate of adverse events over the last ...
Jul 12, 2022
0
9
A voice analysis app used by heart failure patients at home recognizes fluid in the lungs three weeks before an unplanned hospitalization or escalation in outpatient drug treatment. The late breaking research was presented ...
May 23, 2022
0
4
For patients hospitalized for acute heart failure, treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin produces clinical benefit, according to a study published online April 4 in Circulation ...
Apr 13, 2022
0
9
